Journal of Current Glaucoma Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Related articles

VOLUME 15 , ISSUE 1 ( January-April, 2021 ) > List of Articles

Original Article

What Glaucoma Surgical Rate could Serve as a Target for West Africa? A Systematic Review

Egbula N Eni, Winifred Nolan, Bassey Eval, John C Buchan

Keywords : Glaucoma surgical rate, Primary open-angle glaucoma, Systematic review, Target, Trabeculectomy, West Africa

Citation Information : Eni EN, Nolan W, Eval B, Buchan JC. What Glaucoma Surgical Rate could Serve as a Target for West Africa? A Systematic Review. J Curr Glaucoma Pract 2021; 15 (1):19-27.

DOI: 10.5005/jp-journals-10078-1293

License: CC BY-NC 4.0

Published Online: 21-07-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Aim and objective: This study aimed to use the available evidence to model a glaucoma surgical rate (GSR), which could serve as a target for West Africa. Materials and methods: A comprehensive literature search was performed in Medline, Embase, Global Health, and CINAHL, and studies published between January 1, 2000, and June 19, 2020, were retrieved. Study selection, quality appraisal, and data extraction were performed and the results of individual studies aggregated and presented using a narrative synthesis. Using these data, we aimed to construct a target GSR per million population per year that is sufficient to offer trabeculectomy to most patients with glaucoma who are diagnosed, and for whom other treatment options are either ineffective or inappropriate. The findings were then used to develop a trabeculectomy target for West Africa. Results: Initial searches returned 633 references, of which 33 unique studies were eligible for inclusion. The glaucoma prevalence population-based surveys identified, reported a wide range of prevalence of primary open-angle glaucoma (POAG) ranging from 1.0 to 8.4%. The studies on glaucoma medications reported intraocular pressure (IOP)-lowering effects ranging from 12.8% (beta-blockers) to 63.7% (Timolol–Latanoprost combinations). The adherence rate to antiglaucoma medications spanned from 10.3 to 82.3%. Regarding selective laser trabeculoplasty (SLT), only two studies were found. All the studies on trabeculectomy showed a significant reduction in IOPs at different follow-up periods with many reporting the absence of vision-threatening complications. From these available data, a GSR of 50 trabeculectomies was suggested for countries in West Africa. Conclusion: This trabeculectomy target metric is expected to minimize POAG blindness in the West African subregion. Clinical significance: The proposed GSR will enable eye care workers involved in glaucoma care in West Africa to assess their efforts compared with the proposed target. The gap will signal the potential for improvement.

HTML PDF Share
  1. Cook C. Glaucoma in Africa: size of the problem and possible solutions. J Glaucoma 2009;18(2):124–128. DOI: 10.1097/IJG.0b013e318189158c.
  2. Budenz DL, Barton K, Whiteside-De Vos J, et al. Prevalence of glaucoma in an urban West African population: the Tema eye survey. JAMA Ophthalmol 2013;131(5):651–658. DOI: 10.1001/jamaophthalmol.2013.1686.
  3. Kyari F, Entekume G, Rabiu M, et al. A population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey. BMC Ophthalmol 2015;15(176). DOI: 10.1186/s12886-015-0160-6.
  4. Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol 2015;15(111). DOI: 10.1186/s12886-015-0097-9.
  5. Santos MAK, Ayena DK, Kuaovi KR, et al. Compliance with medical treatment in primary open-angle glaucoma in {Lome}. J Fr D Ophtalmol 2016;39(5):459–466. DOI: 10.1016/j.jfo.2015.10.013.
  6. Kizor-Akaraiwe NN. Follow-up and adherence to glaucoma care by newly diagnosed glaucoma patients in Enugu, Nigeria. Ophthalmic Epidemiol 2019;26(2):140–146. DOI: 10.1080/09286586.2018.1555263.
  7. Adekoya BJ, Adepoju FG, Moshood KF, et al. Challenges in the management of glaucoma in a developing country; a qualitative study of providers’ perspectives. Niger J Med 2015;24(4):315–322.
  8. Adekoya B, Akinsola F, Balogun B, et al. Patient refusal of glaucoma surgery and associated factors in Lagos, Nigeria. Middle East Afr J Ophthalmol 2013;20(2):168–173. DOI: 10.4103/0974-9233.110612.
  9. Mansouri K, Medeiros FA, Weinreb RN. Global rates of glaucoma surgery. Graefe's Arch Clin Exp Ophthalmol 2013;251(11):2609–2615. DOI: 10.1007/s00417-013-2464-7.
  10. Burr J, Azuara-Blanco A, Avenell A, et al. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2012(9):CD004399. DOI: 10.1002/14651858.cd004399.pub3.
  11. Hong Q, Pluye P, Fàbregues S, et al. Mixed methods appraisal tool (MMAT) version 2018: user guide. McGill 2018. 1–11. http://mixedmethodsappraisaltoolpublic.pbworks.com/. Accessed June 28, 2020.
  12. Taylor DJ, Hobby AE, Binns AM, et al. How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open 2016;6(12):1–13. DOI: 10.1136/bmjopen-2016-011504.
  13. Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol 2009;9(1):59. DOI: 10.1186/1471-2288-9-59.
  14. Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020;368:1–6. DOI: 10.1136/bmj.l6890.
  15. Balo PK, Wabagira J, Banla M, et al. Specific causes of blindness and vision impairment in a rural area of Southern Togo. J Fr Ophtalmol 2000;23(5):459–464. https://pubmed.ncbi.nlm.nih.gov/10844304/. Accessed June 24, 2020.
  16. Tchabi S, Abouki C, Sounouvou I, et al. Survey of medical treatment in primary open-angle glaucoma. J Fr Ophtalmol 2011;34(9):624–628. DOI: 10.1016/j.jfo.2011.07.009.
  17. Sounouvou I, Tchabi S, Monteiro S, et al. Therapeutics of primary open-angle glaucoma in Cotonou: a series of 224 cases. J Fr Ophtalmol 2012;35(2):100–105. DOI: 10.1016/j.jfo.2011.02.015.
  18. Seck SM, Agboton G, Dieng M, et al. Selective laser trabeculoplasty (SLT): our experience in African blacks. J Fr Ophtalmol 2015;38(3):238–246. DOI: 10.1016/j.jfo.2014.11.002.
  19. Olawoye OO, Ashaye AO, Baiyeroju AM, et al. Outcomes of trabeculectomy with 5-fluorouracil at a Nigerian tertiary hospital. J Ophthalmic Vis Res 2013;8(2):126–133.
  20. Olawoye OO, Ashaye AO. Long term outcomes of augmented trabeculectomy with 5-fluorouracil in Nigeria. J West African Coll Surg 2017;7(1):92–112. http://www.ncbi.nlm.nih.gov/pubmed/29951457. Accessed June 24, 2020.
  21. Mwanza JC, Tulenko SE, Barton K, et al. Eight-year incidence of open-angle glaucoma in the Tema eye survey. Ophthalmology 2019;126(3):372–380. DOI: 10.1016/j.ophtha.2018.10.016.
  22. Agbeja-Baiyeroju AM, Omoruyi M, Owoaje ET. Effectiveness of trabeculectomy on glaucoma patients in Ibadan. Afr J Med Med Sci 2001;30(1-2):39–42. https://pubmed.ncbi.nlm.nih.gov/14510148/. Accessed June 24, 2020.
  23. Anand N, Mielke C, Dawda VK. Trabeculectomy outcomes in advanced glaucoma in Nigeria. Eye 2001;15(3):274–278. DOI: 10.1038/eye.2001.93.
  24. Bekibele CO. Evaluation of 56 trabeculectomy operations at Ago-Iwoye, Ogun State, Nigeria. West Afr J Med 2001;20(3):223–226. https://pubmed.ncbi.nlm.nih.gov/11922155/. Accessed June 24, 2020.
  25. Ashaye AO, Komolafe OO. Post-operative complication of trabeculectomy in Ibadan, Nigeria: Outcome of 1-year follow-up. Eye 2009;23(2):448–452. DOI: 10.1038/sj.eye.6702979.
  26. Adegbehingbe B, Majemgbasan T. A review of trabeculectomies at a Nigerian teaching Hospital. Ghana Med J 2007;41(4):176–180. DOI: 10.4314/gmj.v41i4.55287.
  27. Komolafe OO, Ashaye AO, Bekibele CO, et al. Outcome of trabeculectomy with 5-fluorouracil using releasable suture technique in a Nigerian Tertiary Hospital. West Afr J Med 2011;30(3):173–177. http://www.ncbi.nlm.nih.gov/pubmed/22120481. Accessed April 10, 2020.
  28. Kim HY, Egbert PR, Singh K. Long-term comparison of primary trabeculectomy with 5-fluorouracil versus mitomycin C in West Africa. J Glaucoma 2008;17(7):578–583. DOI: 10.1097/IJG.0b013e31816b304a.
  29. Mielke C, Dawda VK, Anand N. Intraoperative 5-fluorouracil application during primary trabeculectomy in Nigeria: a comparative study. Eye 2003;17(7):829–834. DOI: 10.1038/sj.eye.6700492.
  30. Anand N, Dawda VK. A comparative study of mitomycin C and 5-fluorouracil trabeculectomy in West Africa. Middle East Afr J Ophthalmol 2012;19(1):147–152. DOI: 10.4103/0974-9233.92132.
  31. Leske MC, Wu SY, Honkanen R, et al. Nine-year incidence of pen-angle glaucoma in the Barbados eye studies. Ophthalmology 2007;114(6):1058–1064. DOI: 10.1016/j.ophtha.2006.08.051.
  32. Federal Ministry of Health, Nigeria. The Nigeria National Blindness and Visual Impairment Survey 2005–2007. vol. 1.; 2007. http://iceh.lshtm.ac.uk/files/2014/04/NigeriaSurvey.pdf.
  33. Onakoya A, Mbadugha C. Self-reported adherence rates in glaucoma patients in Southwest Nigeria. J Clin Sci 2016;13(2):51–57. DOI: 10.4103/2408-7408.179649.
  34. Saka SA, Onyeukwu BO, Eze UI. Antiglaucoma medication utilization and therapeutic outcome among Nigerian older persons with primary open angle glaucoma. Bangladesh J Med Sci 2020;19(1): 141–147. DOI: 10.3329/bjms.v19i1.43887.
  35. Brown MT, Bussell J, Dutta S, et al. Medication adherence: truth and consequences. Am J Med Sci 2016;351(4):387–399. DOI: 10.1016/j.amjms.2016.01.010.
  36. Gyasi M, Andrew F, Adjuik M, et al. The effect of medical therapy on IOP control in Ghana. Ghana Med J 2014;48(3):148–152. DOI: 10.4314/gmj.v48i3.5.
  37. Staiger RD, Schwandt H, Puhan MA, et al. Improving surgical outcomes through benchmarking. Br J Surg 2019;106(1):59–64. DOI: 10.1002/bjs.10976.
  38. Lawan A. Pattern of presentation and outcome of surgical management of primary open angle glaucoma in Kano, Northern Nigeria. Ann Afr Med 2007;6(4):180–185. DOI: 10.4103/1596-3519.55700.
  39. Ntim-Amponsah CT, Amoaku WMK, Ofosu-Amaah S, et al. Prevalence of glaucoma in an African population. Eye 2004;18(5):491–497. DOI: 10.1038/sj.eye.6700674.
  40. Koffuor GA, Gyanfosu L, Amoateng P. The efficacy of NHIS-listed anti-glaucoma drugs in the management of primary open-angle glaucoma. J Med Biomed Sci 2012;1(2):50–58. DOI: 10.4314/jmbs.v1i2.
  41. Adio AO, Onua AA. Economic burden of glaucoma in Rivers State, Nigeria. Clin Ophthalmol 2012;6(1):2023–2031. DOI: 10.2147/OPTH.S37145.
  42. Thomas R, Sekhar GC, Kumar RS. Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources. Curr Opin Ophthalmol 2004;15(2):127–131. DOI: 10.1097/00055735-200404000-00012.
  43. Onakoya AO, Olowoyeye AO, Onyekwelu OM, et al. Intraocular pressure changes post selective laser trabeculoplasty in the contralateral untreated eyes of Nigerian patients with primary open angle glaucoma. Nig Q J Hosp Med 2015;25(2):133–138.
  44. Gaasterland DE, Ederer F, Beck A, et al. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130(4):429–440. DOI: 10.1016/S0002-9394(00)00538-9.
  45. OECD. Life Expectancy at Birth: Years, in Country Profiles and OECD Partner Countries. Paris: OECD Publishing; 2017. DOI: 10.1787/how_life-2017-table168-en.
  46. Foster A. Cataract - a global perspective: Output outcome and outlay. Eye 1999;13(3):449–453. DOI: 10.1038/eye.1999.120.
  47. ICHOM, Standard sets. International Consortium for Health Outcomes Measurement. htpps://www.ichom.org/standard-sets/. Accessed December 25, 2020.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.